Thu, December 6, 2012
Wed, December 5, 2012
Tue, December 4, 2012
Mon, December 3, 2012
Sun, December 2, 2012
Sat, December 1, 2012
Fri, November 30, 2012
Thu, November 29, 2012
Wed, November 28, 2012
Tue, November 27, 2012
Mon, November 26, 2012
Sun, November 25, 2012
Fri, November 23, 2012
Thu, November 22, 2012
Wed, November 21, 2012
Tue, November 20, 2012
Mon, November 19, 2012
Sat, November 17, 2012
Fri, November 16, 2012
Thu, November 15, 2012
Wed, November 14, 2012
Tue, November 13, 2012
Mon, November 12, 2012

Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Piper Jaffray 24th Annual Healthcare Conference In New York City O


//health-fitness.news-articles.net/content/2012/ .. al-healthcare-conference-in-new-york-city-o.html
Published in Health and Fitness on Wednesday, November 21st 2012 at 13:15 GMT by Market Wire   Print publication without navigation


Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Piper Jaffray 24th... -- SAN DIEGO, Nov. 21, 2012 /PRNewswire/ --

SAN DIEGO, Nov. 21, 2012 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: [ CADX ]), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company's President and CEO Ted Schroeder will present the company's corporate overview on Wednesday, November 28, 2012 at 10:30am Eastern Time (7:30am Pacific Time) during the Piper Jaffray 24th Annual Healthcare Conference at the New York Palace Hotel in New York City.

The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at [ www.cadencepharm.com ] in the Investors section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.

About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.  The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the "Investors" page of [ www.cadencepharm.com ] under "Events and Presentations." 

 

Contacts:

William R. LaRue

SVP, CFO                                     

Cadence Pharmaceuticals, Inc.

858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.



RELATED LINKS
[ http://www.cadencepharm.com ]

Publication Contributing Sources